Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Butasal-100
Active substances:
Butafosfan+Cyanocobalamin
Estonian, English, Latin
ATC code: QA12CX92
Dosage form: solution for injection
Strength: 100mg+0,05mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated May 7, 2021)
Package information leaflet (PIL): EST  (last updated May 7, 2021)
Labelling:  (last updated May 7, 2021)
Indication: As supportive treatment of metabolic or reproductive disorders. In case of peri-parturient metabolic disorders, tetany and paresis (milk fever), the product should be administered in addition to magnesium and calcium, respectively.
Safety features: No
Marketing authorization holder: Interchemie Werken De Adelaar Eesti aktsiaselts 
Marketing authorization number: 2233 
Marketing authorization issued on: May 5, 2020 
Marketing authorization expires on: May 5, 2025 
Marketing authorization procedure type: Mutual recognition 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported Additional information
1798724  Butasal-100  solution for injection  100mg +0,05mg 1ml 100ml 1TK  Prescription      31.03.2022   
1814150  Butasal-100  solution for injection  100mg +0,05mg 1ml 100ml 6TK  Prescription      31.03.2022   
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere